Phoenix Group to Explore SunLife Sale

Insurance services provider Phoenix Group (LON: PHNX) announced Wednesday that it intends to explore a potential sale of its SunLife Limited business.

SunLife is a leading provider of financial protection products directly to the over-50s market in the UK and reported a profit after tax of £16 million in 2023. Phoenix Group acquired Sunlife and French firm Axa’s UK investment, pensions and insurance businesses for £375 million in 2016.

Phoenix said that after a strategic review, it has concluded that the business is “no longer core to the delivery of its vision of becoming the UK’s leading retirement savings and income business.”

WELCOME BONUS - Free Share Bundle When You Invest £50! Get up to £500 cashback for investing with IG.

Invest in 15,000+ shares and ETFs. Open an account now, invest at least £50, and you’ll get a free share bundle worth between £40 and £200. T&Cs apply.

5.0

Open Account Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 68% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.

As a result, it has decided to begin a sale process, having received several initial expressions of interest from third parties. However, Phoenix warns that there can be no certainty at this stage a disposal will occur and that a further announcement will be made in due course.

Phoenix Group’s stock closed Tuesday’s session up 0.2% at 526.5p a share.

In April, analysts at Barclays slashed their rating for Phoenix Group to Underweight from Overweight, cutting the price target to 500p from 600p a share.

They told investors that Phoenix has insufficient cash from operations alone to support management’s targets. It also highlighted what it sees as a weaker capital position than peers and a dislike for its change in strategy from historical areas of strength to areas where PHNX is not meaningfully differentiated.